Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
6.60
-0.15 (-2.22%)
Dec 5, 2025, 4:00 PM EST - Market closed
Profound Medical Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Profound Medical stock has a target of 11, which predicts a 66.67% increase from the current stock price of 6.6.
Price Target: $11 (+66.67%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 23, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Profound Medical is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Maintains $17 → $11 | Strong Buy | Maintains | $17 → $11 | +66.67% | Apr 23, 2025 |
| Stifel | Stifel | Hold → Strong Buy Upgrades $9 → $12 | Hold → Strong Buy | Upgrades | $9 → $12 | +81.82% | Jul 16, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $13 → $11 | Strong Buy | Maintains | $13 → $11 | +63.64% | Mar 11, 2024 |
| Stifel | Stifel | Hold Maintains $11 → $9 | Hold | Maintains | $11 → $9 | +36.36% | Mar 8, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $14 → $13 | Strong Buy | Maintains | $14 → $13 | +93.18% | Jan 4, 2024 |
Financial Forecast
Revenue This Year
17.54M
from 10.68M
Increased by 64.23%
Revenue Next Year
37.37M
from 17.54M
Increased by 113.06%
EPS This Year
-1.48
from -1.12
EPS Next Year
-1.05
from -1.48
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 18.9M | 41.4M | |||
| Avg | 17.5M | 37.4M | |||
| Low | 16.1M | 34.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 77.0% | 135.9% | |||
| Avg | 64.2% | 113.1% | |||
| Low | 50.5% | 95.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.50 | -0.85 | ||||
| Avg | -1.48 | -1.05 | ||||
| Low | -1.47 | -1.27 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.